Page last updated: 2024-10-27

fenoldopam and Recrudescence

fenoldopam has been researched along with Recrudescence in 1 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Research Excerpts

ExcerptRelevanceReference
"We report the first case of the failure of fenoldopam for a pediatric patient with severe hypertension and renal failure."7.73Failure of fenoldopam to control severe hypertension secondary to renal graft rejection in a pediatric patient. ( Lechner, BL; Pascual, JF; Roscelli, JD, 2005)
"We report the first case of the failure of fenoldopam for a pediatric patient with severe hypertension and renal failure."3.73Failure of fenoldopam to control severe hypertension secondary to renal graft rejection in a pediatric patient. ( Lechner, BL; Pascual, JF; Roscelli, JD, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lechner, BL1
Pascual, JF1
Roscelli, JD1

Other Studies

1 other study available for fenoldopam and Recrudescence

ArticleYear
Failure of fenoldopam to control severe hypertension secondary to renal graft rejection in a pediatric patient.
    Military medicine, 2005, Volume: 170, Issue:2

    Topics: Antihypertensive Agents; Child, Preschool; Fenoldopam; Graft Rejection; Humans; Hypertension; Kidney

2005